We found no difference in the proportion of total ILCs in CD45+ cells between HDs and NSCLC patients; however, the proportions of ILC2s in bulk ILCs obtained from PBMCs and tumor tissues of NSCLC patients were significantly higher than those obtained from HD PBMCs. The gene discussed is PTPRC; the disease is neoplasm.